Buy Norditropin SimpleXx online | Norditropin SimpleXx for sale | Norditropin SimpleXx
GENERAL INFORMATION:
Buy Norditropin SimpleXx online | Norditropin SimpleXx for sale | Norditropin SimpleXx
Manufacturer: Novo Nordisk
Substance: Somatropin (rDNA origin)
Package: 1 Cartridge (15mg/1.5mL)
Common Names
Jintropin, Jintropine, Norditropin, Somatropin, SimpleXx, Hygetropin, Humatrope, Norditropin, Nutropin, Saizen, Biotropin, Zorbtive, Ansomone, Ansomon, Tev-Tropin, Zomacton, Glotropin, Kefei, Kigtropin, Riptropin, Taitropin.
Drug Description
Transparent oily solution.
Norditropin SimpleXx Composition
1 cartridge contains:
Active substance: Human Growth Hormone 10 mg
Bodybuilding Benefits
Human growth hormone in synthetic form used by athletes in periods before contests because of the low detection risk. It offers gains in muscular mass and has the ability to burn fat. It also increases bone density and energy levels thus making the immune system stronger.
Therapeutic Indication
Is considered an ideal drug in battle against aging and is used in surgical operations, as well as for growth hormone treatment and in case of traumas, severe burns, organ transplantations and cancers, promoting protein combination.
Dosage (Men)
4 to 6 IU per day.
Dosage (Women)
2 IU per day.
Active Life
Varies by injection method.
Norditropin SimpleXx Side Effects
Buy Norditropin SimpleXx online | Norditropin SimpleXx for sale | Norditropin SimpleXx
Much as it is low in side effects, it can provoke some headache, nausea, vomiting and edema of ankles, painful joints, baby naps, carpal tunnel syndrome, water retention, morning aches, acromegal and hypoglycemia.
Package Presentation
Comes in 30 IU cartridge (10 mg / 1.5 mL).
Storage
Keep cold (+2-+8°C). Protect from light. Keep out of reach of children.
Buy Norditropin SimpleXx online | Norditropin SimpleXx for sale | Norditropin SimpleXx
Idiopathic short stature (ISS) is one of the most controversial indications for GH as pediatric endocrinologists do not agree on its definition, diagnostic criteria, or limits.
In the late 1990s, the pharmaceutical manufacturer Eli Lilly and Company sponsored trials of Humatrope (their brand of rHGH) in children with extreme ISS, those at least 2.25 standard deviations below mean (in the lowest 1.2 percent of the population). Controversy has arisen as to whether all of these children were truly “short normal” children, since the average IGF1 was low.